Susan J. Done

5.9k citations

106 papers · 3.2k indexed · h-index 35

Molecular Biology top 5%
Oncology top 2%
Cancer Research top 1%
Radiology, Nuclear Medicine and Imaging top 5%
Pathology and Forensic Medicine top 2%

Co-authors: David R. McCready Nona Arneson Raymond M. Reilly Irene L. Andrulis Bruce Youngson Pamela J. Goodwin Martin C. Chang Kristin McLarty
Topics: Breast Cancer Treatment Studies (21 papers)Cancer Genomics and Diagnostics (20 papers)Breast Lesions and Carcinomas (16 papers)
Cited by: Cancer Research Oncology Pathology and Forensic Medicine
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Oncology Molecular Cell
Partner nations: Canada United States United Kingdom

In The Last Decade

Susan J. Done

103 papers receiving 3.1k citations

Peers

Countries citing papers authored by Susan J. Done

Since Specialization

Citations

This map shows the geographic impact of Susan J. Done's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan J. Done with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan J. Done more than expected).

Fields of papers citing papers by Susan J. Done

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan J. Done. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan J. Done. The network helps show where Susan J. Done may publish in the future.

Co-authorship network of co-authors of Susan J. Done

This figure shows the co-authorship network connecting the top 25 collaborators of Susan J. Done. A scholar is included among the top collaborators of Susan J. Done based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan J. Done. Susan J. Done is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Primary MALT lymphoma of the breast: pathological and radiological characteristics 2024 ·Breast Cancer Research and Treatment ·Yukiko Shibahara,Jan Delabie,Supriya Kulkarni,(unknown),Anca Prica,David R. McCready,Susan J. Done	1
2	AI improves accuracy, agreement and efficiency of pathologists for Ki67 assessments in breast cancer 2024 ·Scientific Reports ·(unknown),(unknown),Julien Meyer,(unknown),Wei Shi,D. Androutsos,Anthony Fyles,Fei‐Fei Liu,Susan J. Done,April Khademi	22
3	Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer 2021 ·Proceedings of the National Academy of Sciences ·(unknown),Kiichi Murakami,Andrew Elia,Yukiko Shibahara,Susan J. Done,Stephen A. Wood,Nicholas J. Donato,Pamela S. Ohashi,Michael Reedijk	49
4	Cell invasion in digital microfluidic microgel systems 2020 ·Science Advances ·(unknown),E. Scott,M. Dean Chamberlain,(unknown),Shuailong Zhang,Susan J. Done,Aaron R. Wheeler	34
5	Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical‐sonography features helping to differentiate fibroadenomas and phyllodes tumor? 2020 ·Journal of Surgical Oncology ·(unknown),Anabel M. Scaranelo,Rachel Fleming,Supriya Kulkarni,Ravi Menezes,David R. McCready,Susan J. Done,Vivianne Freitas	7
6	Modelling the MYC-driven normal-to-tumour switch in breast cancer 2019 ·Disease Models & Mechanisms ·Corey Lourenco,Manpreet Kalkat,Kathleen E. Houlahan,Jason De Melo,Joseph Longo,Susan J. Done,Paul C. Boutros,Linda Z. Penn	17
7	Annual vs Biennial Screening: Diagnostic Accuracy Among Concurrent Cohorts Within the Ontario Breast Screening Program 2019 ·JNCI Journal of the National Cancer Institute ·Anna M. Chiarelli,Kristina M. Blackmore,Lucia Mirea,Susan J. Done,Vicky Majpruz,Ashini Weerasinghe,Linda Rabeneck,Derek Muradali	14
8	Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program 2019 ·JNCI Journal of the National Cancer Institute ·Anna M. Chiarelli,Kristina M. Blackmore,Derek Muradali,Susan J. Done,Vicky Majpruz,Ashini Weerasinghe,Lucia Mirea,Andrea Eisen,Linda Rabeneck,Ellen Warner	56
9	Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation 2016 ·International Journal of Molecular Sciences ·Lori E. Lowes,Scott V. Bratman,Ryan Dittamore,Susan J. Done,Shana O. Kelley,Sabine Mai,Ryan D. Morin,Alexander W. Wyatt,Alison L. Allan	53
10	Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients 2015 ·Cancer Research ·(unknown),Jessica R. Adams,Jeff C. Liu,Amanda J. Loch,Ruth G. Wong,(unknown),(unknown),(unknown),(unknown),(unknown),Timothy F. Lane,Sergei B. Koralov,Susan J. Done,James R. Woodgett,Eldad Zacksenhaus,Pingzhao Hu,Sean E. Egan	48
11	B7-H4 Expression by Nonhematopoietic Cells in the Tumor Microenvironment Promotes Antitumor Immunity 2014 ·Cancer Immunology Research ·Ramtin Rahbar,Albert Lin,Magar Ghazarian,Helen Loo Yau,(unknown),Philipp A. Lang,Anita Schildknecht,Alisha R. Elford,Carlos R. Garcia-Batres,Bernard Martin,Hal K. Berman,Wey L. Leong,David R. McCready,Michael Reedijk,Susan J. Done,Naomi Miller,Bruce Youngson,Woong‐Kyung Suh,Tak W. Mak,Pamela S. Ohashi	38
12	Embryonic Protein Nodal Promotes Breast Cancer Vascularization 2012 ·Cancer Research ·Daniela F. Quail,Logan A. Walsh,Guihua Zhang,Scott D. Findlay,Juan Carlos Alvarez Moreno,(unknown),Amber Ablack,John D. Lewis,Susan J. Done,David A. Hess,Lynne‐Marie Postovit	34
13	Proteomic Analyses Reveal High Expression of Decorin and Endoplasmin (HSP90B1) Are Associated with Breast Cancer Metastasis and Decreased Survival 2012 ·PLoS ONE ·Thomas R. Cawthorn,Juan Carlos Alvarez Moreno,Moyez Dharsee,Danh Tran‐Thanh,Suzanne Ackloo,(unknown),Girish Sardana,Jian Chen,Peter Kupchak,Lindsay M. Jacks,Naomi Miller,Bruce Youngson,Vladimir V. Iakovlev,Cynthia J. Guidos,Katherine A. Vallis,Kenneth Evans,David R. McCready,Wey L. Leong,Susan J. Done	70
14	Role of Antibody-Mediated Tumor Targeting and Route of Administration in Nanoparticle Tumor Accumulation in Vivo 2012 ·Molecular Pharmaceutics ·Niladri Chattopadhyay,Humphrey Fonge,Zhongli Cai,Deborah A. Scollard,Eli Lechtman,Susan J. Done,Jean‐Philippe Pignol,Raymond M. Reilly	82
15	Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens 2011 ·BMC Cancer ·Al Muktafi Sadi,Dong‐Yu Wang,Bruce Youngson,Naomi Miller,Scott Boerner,Susan J. Done,Wey L. Leong	31
16	Antitumor Effects and Normal-Tissue Toxicity of ¹¹¹In-Nuclear Localization Sequence-Trastuzumab in Athymic Mice Bearing HER-Positive Human Breast Cancer Xenografts 2010 ·Journal of Nuclear Medicine ·Danny L. Costantini,Kristin McLarty,Helen Lee,Susan J. Done,Katherine A. Vallis,Raymond M. Reilly	61
17	Micro-SPECT/CT with ¹¹¹In-DTPA-Pertuzumab Sensitively Detects Trastuzumab-Mediated HER2 Downregulation and Tumor Response in Athymic Mice Bearing MDA-MB-361 Human Breast Cancer Xenografts 2009 ·Journal of Nuclear Medicine ·Kristin McLarty,Bart Cornelissen,Zhongli Cai,Deborah A. Scollard,Danny L. Costantini,Susan J. Done,Raymond M. Reilly	58
18	¹⁸F-FDG Small-Animal PET/CT Differentiates Trastuzumab-Responsive from Unresponsive Human Breast Cancer Xenografts in Athymic Mice 2009 ·Journal of Nuclear Medicine ·Kristin McLarty,(unknown),Deborah A. Scollard,Susan J. Done,Douglass Vines,David E. Green,Danny L. Costantini,Raymond M. Reilly	33
19	Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study 2008 ·Clinical Cancer Research ·Vladimir V. Iakovlev,Nona Arneson,(unknown),Chunjie Wang,(unknown),(unknown),(unknown),Melania Pintilie,Susan J. Done	43
20	Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts 2008 ·European Journal of Nuclear Medicine and Molecular Imaging ·Kristin McLarty,Bart Cornelissen,Deborah A. Scollard,Susan J. Done,Kathy Chun,Raymond M. Reilly	103

About Susan J. Done

Susan J. Done is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 106 papers that have together received 3.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (21 papers), Cancer Genomics and Diagnostics (20 papers) and Breast Lesions and Carcinomas (16 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.3k citations) and Pathology and Forensic Medicine (477 citations). Susan J. Done has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include David R. McCready, Nona Arneson, Raymond M. Reilly, Irene L. Andrulis, Bruce Youngson, Pamela J. Goodwin, Martin C. Chang, Kristin McLarty, Deborah A. Scollard and Wey L. Leong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact